Gabapentin not effective for chronic pelvic pain in women

doi:10.1136/dtb.2021.000035

Gabapentin not effective for chronic pelvic pain in women

In: Drug and Therapeutics Bulletin · 2021 · vol. 59(8) , pp. 115 · doi:10.1136/dtb.2021.000035 · PMID:34193515 · W4205297405

article OA: closed CC0

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

A randomized, double-blind, placebo-controlled trial found that gabapentin was not effective for treating chronic pelvic pain in women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Review of: Horne AW, Vincent K, Hewitt CA, et al . Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet . 2020; 396:909–17.

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial 2020

References (1)

Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial via openalex

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall: last seen: 2026-10-01T06:38:16.588661+00:00

License: CC0 · commercial use OK

[1] Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial 2020